{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T07:12:44Z","timestamp":1768029164574,"version":"3.49.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.arteri.2016.03.002","type":"journal-article","created":{"date-parts":[[2016,4,30]],"date-time":"2016-04-30T14:04:02Z","timestamp":1462025042000},"page":"178-187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Effects of a nutraceutical combination containing berberine (BRB), policosanol, and red yeast rice (RYR), on lipid profile in hypercholesterolemic patients: A meta-analysis of randomised controlled trials"],"prefix":"10.1016","volume":"28","author":[{"given":"Jesus","family":"Mill\u00e1n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arrigo F.G.","family":"Cicero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Anguera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arteri.2016.03.002_bib0245","unstructured":"World Health Organization. Media centre. Cardiovascular diseases (CVDs). Fact sheet N\u00b0317 September 2012. http:\/\/www.who.int\/mediacentre\/factsheets\/fs317\/en\/index.html# [accessed 28.01.13]."},{"key":"10.1016\/j.arteri.2016.03.002_bib0250","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case\u2013control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.arteri.2016.03.002_bib0255","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/01.ATV.0000251503.35795.4f","article-title":"Biomarkers of atherosclerotic plaque instability and rupture","volume":"27","author":"Koenig","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.arteri.2016.03.002_bib0260","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nature05487","article-title":"Mechanisms linking obesity with cardiovascular disease","volume":"444","author":"Van Gaal","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.arteri.2016.03.002_bib0265","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1126\/science.1148032","article-title":"Physiology. An integrative view of obesity","volume":"318","author":"Wisse","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.arteri.2016.03.002_bib0270","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the trial report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","volume":"285","author":"Cleeman","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.arteri.2016.03.002_bib0275","doi-asserted-by":"crossref","first-page":"769","DOI":"10.7326\/0003-4819-132-10-200005160-00002","article-title":"Cost-effectiveness of cholesterol lowering therapies according to patient characteristics","volume":"132","author":"Prosser","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.arteri.2016.03.002_bib0280","unstructured":"U.S. Food and Drug Administration. FDA. Dietary Supplements. Version current 6 March 2010. http:\/\/www.fda.gov\/AboutFDA\/Transparency\/Basics\/ucm193949.htm [accessed 28.01.13]."},{"key":"10.1016\/j.arteri.2016.03.002_bib0285","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4330\/wjc.v4.i3.77","article-title":"A nutraceutical combination improves insulin sensitivity in patients with metabolic syndrome","volume":"4","author":"Affuso","year":"2012","journal-title":"World J Cardiol"},{"key":"10.1016\/j.arteri.2016.03.002_bib0290","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1476-511X-11-123","article-title":"Nutraceutical pill containing berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial hypercholesterolemia on stable cholesterol-lowering treatment","volume":"11","author":"Pisciotta","year":"2012","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.arteri.2016.03.002_bib0295","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1097\/HJH.0b013e3283395208","article-title":"Effects of nutraceuticals on prevalence of metabolic syndrome and on calculated Framingham Risk Score in individuals with dyslipidemia","volume":"28","author":"Izzo","year":"2010","journal-title":"J Hypertens"},{"key":"10.1016\/j.arteri.2016.03.002_bib0300","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3233\/s12349-010-0043-6","article-title":"Clinical evidence of efficacy of red yeast rice and berberine in a large controlled study versus diet","volume":"4","author":"Trimarco","year":"2011","journal-title":"Med J Nutr Metab"},{"key":"10.1016\/j.arteri.2016.03.002_bib0305","doi-asserted-by":"crossref","first-page":"264e9","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.arteri.2016.03.002_bib0310","unstructured":"R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0. http:\/\/www.R-project.org\/ [accessed 16.12.13]."},{"key":"10.1016\/j.arteri.2016.03.002_bib0315","series-title":"Statistical methods for meta-analysis","author":"Hedges","year":"1985"},{"key":"10.1016\/j.arteri.2016.03.002_bib0320","series-title":"Statistical power analysis for the behavioral sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.arteri.2016.03.002_bib0325","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","article-title":"A power primer","volume":"112","author":"Cohen","year":"1992","journal-title":"Psychol Bull"},{"key":"10.1016\/j.arteri.2016.03.002_bib0330","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.numecd.2009.05.017","article-title":"Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study","volume":"20","author":"Affuso","year":"2010","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.arteri.2016.03.002_bib0335","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4330\/wjc.v4.i3.77","article-title":"A nutraceutical combination improves insulin sensitivity in patients with metabolic syndrome","volume":"4","author":"Afusso","year":"2012","journal-title":"World J Cardiol"},{"key":"10.1016\/j.arteri.2016.03.002_bib0340","first-page":"26","article-title":"Eulipidemic effects of berberine administered alone or in combination with other natural cholesterol-lowering agents. A single-blind clinical investigation","volume":"57","author":"Cicero","year":"2007","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.arteri.2016.03.002_bib0345","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s13749-012-0018-y","article-title":"Long-term efficacy and tolerability of a multicomponent lipid-lowering nutraceutical in overweight patients","volume":"11","author":"Cicero","year":"2012","journal-title":"Nutrafoods"},{"key":"10.1016\/j.arteri.2016.03.002_bib0350","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1097\/HJH.0b013e3283395208","article-title":"Effects of nutraceuticals on prevalence of metabolic syndrome and on calculated Framingham Risk Score in individuals with dyslipidemia","volume":"28","author":"Izzo","year":"2010","journal-title":"J Hypertens"},{"key":"10.1016\/j.arteri.2016.03.002_bib0355","series-title":"41 Congreso Nacional de Cardiolog\u00eda ANMCO 2010","article-title":"Complemento nutricionlal de Levadura Roja, Policosanoles, Berberina, \u00c1cido F\u00f3lico y antioxidantes, en pacientes con hipercolesterolemia en prevenci\u00f3n secundaria","author":"Macchi","year":"2010"},{"key":"10.1016\/j.arteri.2016.03.002_bib0360","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s12325-011-0082-5","article-title":"Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients","volume":"28","author":"Marazzi","year":"2011","journal-title":"Adv Ther"},{"key":"10.1016\/j.arteri.2016.03.002_bib0365","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1476-511X-11-123","article-title":"Nutraceutical pill containing berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial hypercholesterolemia on stable cholesterol-lowering treatment","volume":"11","author":"Pisciotta","year":"2012","journal-title":"Lipids Health Dis"},{"issue":"August (8)","key":"10.1016\/j.arteri.2016.03.002_bib0370","doi-asserted-by":"crossref","first-page":"e101978","DOI":"10.1371\/journal.pone.0101978","article-title":"Effects of combined bioactive compounds on lipid profile and clinical criteria for metabolic syndrome in a hypercholesterolemic population with low cardiovascular disease risk: a multicenter randomized trial","volume":"9","author":"Sol\u00e0","year":"2014","journal-title":"PLOS ONE"},{"key":"10.1016\/j.arteri.2016.03.002_bib0375","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s12349-010-0043-6","article-title":"Clinical evidence of efficacy of red yeast rice and berberine in a large controlled study versus diet","volume":"4","author":"Trimarco","year":"2011","journal-title":"Med J Nutr Metab"},{"key":"10.1016\/j.arteri.2016.03.002_bib0380","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.phanu.2013.02.003","article-title":"Nutraceutical combination (red yeast rice, berberine and policosanols) improves aortic stiffness in low-moderate risk hypercholesterloemic patients","author":"Pirro","year":"2013","journal-title":"PharmaNutrition"},{"key":"10.1016\/j.arteri.2016.03.002_bib0385","first-page":"A8523","article-title":"Randomized trial of Nutraceuticals in statin-intolerant patients treated with Percutaneous coronary intervention","volume":"124","author":"Pellicia","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.arteri.2016.03.002_bib0390","series-title":"Comunicaci\u00f3n en XXVI Congreso Nacional de la Sociedad Espa\u00f1ola de Arteriosclerosis","article-title":"Efectos de una combinaci\u00f3n de sustancias bioactivas (armolipid plus) sobre el perfil lip\u00eddico y los criterios cl\u00ednicos del s\u00edndrome metab\u00f3lico. Estudio multic\u00e9ntrico, aleatorizado, doble ciego controlado con placebo","author":"Puzo","year":"2013"},{"key":"10.1016\/j.arteri.2016.03.002_bib0395","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2174\/1876526201305010018","article-title":"Effect of a lipid-lowering nutraceutical on pulse-wave-velocity in hypercholesterolemic patients with or without chronic kidney disease","volume":"5","author":"Cicero","year":"2013","journal-title":"Open Hypertens J"},{"key":"10.1016\/j.arteri.2016.03.002_bib0400","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jacl.2010.07.001","article-title":"Role of dietary supplements in lowering low-density lipoprotein cholesterol","volume":"4","author":"Nijjar","year":"2010","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.arteri.2016.03.002_bib0405","first-page":"312","article-title":"Antiatherosclerotic efficacy of policosanol, red yeast rice extract and astaxanthin in the rabbit","volume":"55","author":"Setnikar","year":"2005","journal-title":"Arzneimittel-Forschung (Drug Res)"},{"key":"10.1016\/j.arteri.2016.03.002_bib0410","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.2337\/db06-0006","article-title":"Berberine, a natural plant product, activates AMPC-activated Protein Kinase with beneficial metabolic effects in diabetic and insulin-resistant states","volume":"55","author":"Lee","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.arteri.2016.03.002_bib0415","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/(SICI)1099-1573(1998)12:1+<S60::AID-PTR251>3.0.CO;2-J","article-title":"Agonist-dependent differential effects of berberine in human platelet aggregation","volume":"12","author":"Shah","year":"1998","journal-title":"Phytother Res"},{"key":"10.1016\/j.arteri.2016.03.002_bib0420","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1046\/j.1440-1681.2002.03746.x","article-title":"Antiplatelet effects of policosanol (20 and 40mg\/day) in healthy volunteers and dyslipidaemic patients","volume":"29","author":"Arruzazabala","year":"2002","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.arteri.2016.03.002_bib0425","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1517\/14712598.2012.704014","article-title":"Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials","volume":"12","author":"Derosa","year":"2012","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.arteri.2016.03.002_bib0430","first-page":"41","article-title":"Berberine induced improvement in hepatic stateatosis index in overweight dyslipidaemic patients treated with lipid-lowering nutraceuticals","volume":"11","author":"Cicero","year":"2013","journal-title":"Curr Top Nutraceutical Res"},{"key":"10.1016\/j.arteri.2016.03.002_bib0435","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2217\/clp.09.41","article-title":"Metabolic and cardiovascular effects of berberine: from preclinical evidences to clinical trial results","volume":"4","author":"Cicero","year":"2009","journal-title":"Clin Lipidol"},{"key":"10.1016\/j.arteri.2016.03.002_bib0440","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/nm1135","article-title":"Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins","volume":"10","author":"Kong","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.arteri.2016.03.002_bib0445","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/ajcn\/69.2.231","article-title":"Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement","volume":"69","author":"Heber","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.arteri.2016.03.002_bib0485","doi-asserted-by":"crossref","first-page":"830","DOI":"10.7326\/0003-4819-150-12-200906160-00006","article-title":"Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial","volume":"150","author":"Becker","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.arteri.2016.03.002_bib0490","first-page":"27","article-title":"Effects of successive dose increases of policosanol on the lipid profile in patients with type II hypercholesterolaemia and tolerability to treatment","volume":"14","author":"Pons","year":"1994","journal-title":"Int J Clin Pharmacol Res"},{"key":"10.1016\/j.arteri.2016.03.002_bib0455","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1079\/BJN20061715","article-title":"Effects of a policosanol supplement on serum lipid concentrations in hypercholesterolaemic and heterozygous familial hypercholesterolaemic subjects","volume":"95","author":"Greyling","year":"2006","journal-title":"Br J Nutr"},{"key":"10.1016\/j.arteri.2016.03.002_bib0460","first-page":"121","article-title":"Long-term effectiveness and safety of a nutraceutical based approach to reduce cholesterolemia in statin intolerant subjects with and without metabolic syndrome","volume":"7","author":"Cicero","year":"2009","journal-title":"Curr Top Nutraceutical Res"},{"key":"10.1016\/j.arteri.2016.03.002_bib0465","doi-asserted-by":"crossref","DOI":"10.1007\/s40292-014-0052-5","article-title":"Berberine and monacolin effects on the cardiovascular risk profile of women with oestroprogestin-induced hypercholesterolemia","author":"Cicero","year":"2014","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"10.1016\/j.arteri.2016.03.002_bib0470","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.atherosclerosis.2014.04.016","article-title":"Factors associated with 2-year persistence in fully non reimbursed lipid-lowering treatments","volume":"235","author":"Cicero","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.arteri.2016.03.002_bib0475","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1471-2288-12-111","article-title":"Investigating clinical heterogeneity in systematic reviews: a methodologic review of guidance in the literature","volume":"12","author":"Gagnier","year":"2012","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.arteri.2016.03.002_bib0480","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1097\/JTO.0b013e31822461b0","article-title":"Systematic reviews and meta analysis of published studies: an overview and best practices","volume":"6","author":"Mandrekar","year":"2011","journal-title":"J Thorac Oncol"}],"container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916816300250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916816300250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T05:42:03Z","timestamp":1567834923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0214916816300250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0214916816300250"],"URL":"https:\/\/doi.org\/10.1016\/j.arteri.2016.03.002","relation":{},"ISSN":["0214-9168"],"issn-type":[{"value":"0214-9168","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of a nutraceutical combination containing berberine (BRB), policosanol, and red yeast rice (RYR), on lipid profile in hypercholesterolemic patients: A meta-analysis of randomised controlled trials","name":"articletitle","label":"Article Title"},{"value":"Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arteri.2016.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Sociedad Espa\u00f1ola de Arteriosclerosis. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}